Bexarotene-activated PPARδ promotes neuroprotection by restoring bioenergetic and quality control homeostasis

Por Dickey, Audrey S., Sanchez, Dafne N., Arreola, Martin, Sampat, Kunal R., Fan, Weiwei, Arbez, Nicolas, Akimov, Sergey, Van Kanegan, Michael J., Ohnishi, Kohta, Gilmore-Hall, Stephen K., Flores, April L., Nguyen, Janice M., Lomas, Nicole, Hsu, Cynthia L., Lo, Donald C., Ross, Christopher A., Masliah, Eliezer, Evans, Ronald M., La Spada, Albert R.
Publicado no Sci Transl Med (2017)

PPARδ repression in Huntington’s disease and its essential role in CNS translate into a potent agonist therapy

Por Dickey, Audrey S., Pineda, Victor V., Tsunemi, Taiji, Liu, Patrick P., Miranda, Helen C., Gilmore-Hall, Stephen K., Lomas, Nicole, Sampat, Kunal R., Buttgereit, Anne, Torres, Mark-Joseph Manalang, Flores, April L., Arreola, Martin, Arbez, Nicolas, Akimov, Sergey S., Gaasterland, Terry, Lazarowski, Eduardo R., Ross, Christopher A., Yeo, Gene W., Sopher, Bryce L., Magnuson, Gavin K., Pinkerton, Anthony B., Masliah, Eliezer, La Spada, Albert R.
Publicado no Nat Med (2015)